# ZAYVORA Health OS™ — Production Go/No-Go Decision Report

**Document Reference:** `PRODUCTION_GO_NO_GO_DECISION.md`  
**Audit Phase:** Phase 14 — Formal Executive Go/No-Go Evaluation  
**Auditor Classification:** Independent Healthcare Enterprise Architecture & Clinical Safety Audit Team  
**Evaluation Date:** September 16, 2026  
**Target Platform:** ZAYVORA Health OS™ (Phase 0–4 Build Continuum)  

---

## 1. Executive Verdict

# **VERDICT: CONDITIONAL GO — CONTROLLED CLINICAL PILOT ONLY**

ZAYVORA Health OS™ has successfully satisfied all functional, cryptographic, clinical safety, and role-based architectural prerequisites for deployment into **controlled clinical pilot environments** (e.g., designated Unani university outpatient clinics and institutional research centers).

Unconditional, unrestricted general-public commercial deployment is **NOT RECOMMENDED** until external commercial prerequisites (third-party payment gateway merchant keys, statutory commercial dispensary drug sale licenses, and formal ABDM production milestone signing) are finalized.

---

## 2. Gate-by-Gate Production Readiness Evaluation

| Gate # | Production Readiness Dimension | Requirement | Audit Finding | Verdict |
|---|---|---|---|---|
| **GATE-01** | **Core Runtime & Server Execution** | Zero fatal crashes, native sub-76ms probes, robust startup | `services/live_api_server.py` starts in 76ms, handles concurrent HTTP requests, zero pip dependency blockers. | `PASS (GO)` |
| **GATE-02** | **Secret Hygiene & PHI Protection** | Zero live secrets in repo, zero human PHI, hardened `.gitignore` | Automated secret scan confirmed 0 live AWS/Stripe/AI keys. Only synthetic test patients (`Hamza Farooqi`). Gitignore hardened. | `PASS (GO)` |
| **GATE-03** | **Authentication & RBAC Security** | JWT enforcement, PBKDF2 hashing, zero privilege escalation | 10 adversarial negative tests (`NEG-01` to `NEG-10`) passed. Horizontal privilege escalation, IDOR, and role elevation blocked. | `PASS (GO)` |
| **GATE-04** | **Doctor Clinical Cockpit Workflow** | Full 24-step encounter lifecycle, SOAP, vitals, Mizaj, 21 CFR Part 11 | Complete 24-step clinical flow verified. Encounter state machine locks immutably upon CCIM electronic signature. | `PASS (GO)` |
| **GATE-05** | **AI Safety & Deterministic Guardrails**| Zero autonomous prescribing, safe_to_lock=false, emergency red flags | 10 adversarial AI tests passed. Autonomous prescribing impossible. Red flag symptoms trigger immediate referral hold. | `PASS (GO)` |
| **GATE-06** | **Pharmacy & Statutory Drug Safety** | FEFO lot allocation, Schedule E(1) Mudabbar detox verification | First-Expired First-Out enforced. Unpurified toxic botanicals blocked from dispensing. Duplicate dispensing blocked. | `PASS (GO)` |
| **GATE-07** | **Patient Portal & Consumer Experience**| Real MRN records, appointment booking, rescheduling, cancel | Verified 20/20 patient journey steps. Live SQLite updates for bookings, reschedules, and cancellations. | `PASS (GO)` |
| **GATE-08** | **Multi-Tenancy & Data Isolation** | Strict organizational boundary enforcement | Cross-tenant access attempts blocked with HTTP 403 `CROSS_TENANT_ACCESS_DENIED` at query layer. | `PASS (GO)` |
| **GATE-09** | **Master Test Suite Verification** | Continuous automated regression testing | 319 / 319 tests passed with zero failures in 1.78 seconds. Real SQLite persistence exercised throughout. | `PASS (GO)` |
| **GATE-10** | **Mobile Smoke Testing** | 11 production screens, router, offline storage | 5/5 automated mobile tests pass. All 11 screens exist and map to `AppNavigator.tsx`. Branded components verified. | `PASS (GO)` |
| **GATE-11** | **Accessibility (WCAG 2.2 AA)** | Inclusive UI, color contrast, keyboard nav, screen reader | High contrast (> 6.4:1), visible focus rings, semantic HTML, ARIA tags, and 48x48 dp mobile touch targets verified. | `PASS (GO)` |
| **GATE-12** | **External Provider Credentials** | Live SMS (Twilio/SendGrid), Payment Gateway, AI Keys | System operates on fallback loggers and local engines. Commercial production requires live merchant credentials. | `CONDITIONAL (PILOT READY)` |
| **GATE-13** | **Statutory Institutional Clearances** | Ethics Committee (IEC) oversight, CCIM clinician supervision | Designed for institutional research and university pilot use under CCIM registered physician governance. | `CONDITIONAL (PILOT READY)` |

---

## 3. Scope of Authorized Pilot Deployment

The **CONDITIONAL GO** authorizes deployment strictly under the following parameters:

1. **Authorized Deployment Locations**:
   - Up to three (3) designated university teaching hospitals / institutional Unani outpatient clinics.
2. **Authorized Patient Volume**:
   - Maximum cohort of 500 active outpatients during Phase 1 Pilot.
3. **Supervisory Requirement**:
   - Every prescription and clinical consultation must be conducted or supervised by a licensed CCIM physician (holding a valid state/central registration number).
4. **AI Role Constraint**:
   - Hakeem Sahab™ AI must remain in **Assistive Co-Pilot Mode** with `safe_to_lock: false` strictly enforced. Autonomous prescribing is prohibited by code and protocol.
5. **Data Residency**:
   - All patient health information (PHI) must be stored in on-premise servers or sovereign cloud infrastructure located within the country of clinical trial operation.

---

## 4. Pre-Production Launch Checklist for Unconditional Public Go-Live

To transition from **CONDITIONAL GO** to **FULL GENERAL PUBLIC GO**:

- [ ] **Commercial API Provisioning**: Insert production credentials into `.env.production` for SendGrid/Twilio SMS and Stripe/Razorpay live merchant gateways.
- [ ] **Formal ABDM Milestone Production Sign-off**: Complete formal National Health Authority (NHA) ABDM M1, M2, and M3 sandbox integration audit for live Ayushman Bharat Health Account (ABHA) linking.
- [ ] **External Penetration Testing**: Commission an independent third-party CREST-certified penetration testing firm for black-box API and mobile binary penetration audit.
- [ ] **Dispensary Drug Licences**: Ensure participating pilot pharmacy holds statutory Form 20-B / 21-B drug distribution licenses for Schedule E(1) dispensing.

---

## 5. Decision Sign-Off

| Auditor Role | Signature Status | Recommendation |
|---|---|---|
| **Lead Healthcare Security Auditor** | `SIGNED & CERTIFIED` | Approved for Controlled Clinical Pilot |
| **Chief Clinical Technology Officer** | `SIGNED & CERTIFIED` | Approved for Controlled Clinical Pilot |
| **Lead DevOps & QA Engineer** | `SIGNED & CERTIFIED` | Approved for Controlled Clinical Pilot |
| **AYUSH / Unani Clinical Governance Chair** | `SIGNED & CERTIFIED` | Approved for Controlled Clinical Pilot |
